phosphotyrosine has been researched along with alvocidib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akyuz, C; Chauhan, D; Corey, SJ; Roginskaya, V; Semenov, I | 1 |
1 other study(ies) available for phosphotyrosine and alvocidib
Article | Year |
---|---|
Growth inhibition and apoptosis of myeloma cells by the CDK inhibitor flavopiridol.
Topics: ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation; Antineoplastic Agents; Apoptosis; Bone Marrow Cells; Cell Division; Cell Survival; Cyclin-Dependent Kinases; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Humans; JNK Mitogen-Activated Protein Kinases; Membrane Glycoproteins; Mitogen-Activated Protein Kinases; Multiple Myeloma; NAD+ Nucleosidase; Phosphotyrosine; Piperidines; src-Family Kinases; Tumor Cells, Cultured | 2002 |